[go: up one dir, main page]

FR2880626B1 - Derives de la purine, compositions les contenant et utilisation - Google Patents

Derives de la purine, compositions les contenant et utilisation

Info

Publication number
FR2880626B1
FR2880626B1 FR0500349A FR0500349A FR2880626B1 FR 2880626 B1 FR2880626 B1 FR 2880626B1 FR 0500349 A FR0500349 A FR 0500349A FR 0500349 A FR0500349 A FR 0500349A FR 2880626 B1 FR2880626 B1 FR 2880626B1
Authority
FR
France
Prior art keywords
purine
derivatives
compositions containing
containing same
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0500349A
Other languages
English (en)
Other versions
FR2880626A1 (fr
Inventor
Chantal Carrez
Florence Fassy
Patrick Maillet
Fabienne Thompson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to FR0500349A priority Critical patent/FR2880626B1/fr
Priority to EP06709072A priority patent/EP1841769A2/fr
Priority to JP2007550815A priority patent/JP2008526930A/ja
Priority to ARP060100113A priority patent/AR052454A1/es
Priority to PCT/FR2006/000065 priority patent/WO2006075094A2/fr
Publication of FR2880626A1 publication Critical patent/FR2880626A1/fr
Priority to US11/773,572 priority patent/US20080119467A1/en
Application granted granted Critical
Publication of FR2880626B1 publication Critical patent/FR2880626B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0500349A 2005-01-13 2005-01-13 Derives de la purine, compositions les contenant et utilisation Expired - Fee Related FR2880626B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0500349A FR2880626B1 (fr) 2005-01-13 2005-01-13 Derives de la purine, compositions les contenant et utilisation
EP06709072A EP1841769A2 (fr) 2005-01-13 2006-01-11 Derives de la purine, compositions les contenant et leurs utilisation contre le cancer
JP2007550815A JP2008526930A (ja) 2005-01-13 2006-01-11 プリン誘導体、プリン誘導体を含有する組成物およびこの使用
ARP060100113A AR052454A1 (es) 2005-01-13 2006-01-11 Derivados de purina, composiciones que los contienen y su utilizacion
PCT/FR2006/000065 WO2006075094A2 (fr) 2005-01-13 2006-01-11 Derives de la purine, compositions les contenant et leurs utilisation contre le cancer
US11/773,572 US20080119467A1 (en) 2005-01-13 2007-07-05 Purine Derivatives, Compositions Containing Them and Use Thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0500349A FR2880626B1 (fr) 2005-01-13 2005-01-13 Derives de la purine, compositions les contenant et utilisation

Publications (2)

Publication Number Publication Date
FR2880626A1 FR2880626A1 (fr) 2006-07-14
FR2880626B1 true FR2880626B1 (fr) 2008-04-18

Family

ID=34954725

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0500349A Expired - Fee Related FR2880626B1 (fr) 2005-01-13 2005-01-13 Derives de la purine, compositions les contenant et utilisation

Country Status (6)

Country Link
US (1) US20080119467A1 (fr)
EP (1) EP1841769A2 (fr)
JP (1) JP2008526930A (fr)
AR (1) AR052454A1 (fr)
FR (1) FR2880626B1 (fr)
WO (1) WO2006075094A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY179032A (en) 2004-10-25 2020-10-26 Cancer Research Tech Ltd Ortho-condensed pyridine and pyrimidine derivatives (e.g.purines) as protein kinase inhibitors
EP2043655A2 (fr) 2006-04-25 2009-04-08 Astex Therapeutics Limited Derives de purine et de deazapurine comme composes pharmaceutiques
JP2010500292A (ja) * 2006-08-09 2010-01-07 メルク フロスト カナダ リミテツド ステアロイル−補酵素ａデルタ−９デサチュラーゼ阻害剤としてのアザシクロアルカン誘導体
WO2008075007A1 (fr) * 2006-12-21 2008-06-26 Cancer Research Technology Limited Composé bicyclohétéroarylés substitué par morpholino et leur utilisation en tant qu'agents anti-cancer
US20080233127A1 (en) * 2007-03-21 2008-09-25 Wyeth Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitors
PL2201012T3 (pl) 2007-10-11 2014-11-28 Astrazeneca Ab Pochodne pirolo[2,3-d]pirymidyny jako inhibitory kinazy białkowej b
EP2923734B1 (fr) * 2009-03-13 2018-01-10 Katholieke Universiteit Leuven, K.U. Leuven R&D Analogues de purines et leur utilisation en tant qu'agents immunosuppresseurs
LT2694056T (lt) 2011-04-01 2019-12-10 Astrazeneca Ab Terapinis gydymas
ES2762250T5 (es) 2011-11-30 2023-01-05 Astrazeneca Ab Tratamiento combinado del cáncer
AU2013204533B2 (en) 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms
WO2013182612A1 (fr) * 2012-06-07 2013-12-12 Bayer Pharma Aktiengesellschaft Inhibiteurs de transport du glucose
ES2833473T3 (es) * 2015-04-21 2021-06-15 Chengdu Zenitar Biomedical Tech Co Ltd Derivados de purinil-N-hidroxil pirimidin formamida, método de preparación y uso de los mismos
CZ306434B6 (cs) * 2015-10-26 2017-01-18 Ústav experimentální botaniky AV ČR, v. v. i. 2,6-disubstituované puriny pro použití jako léčiva, a farmaceutické přípravky
CZ306987B6 (cs) * 2015-10-26 2017-11-01 Ústav experimentální botaniky AV ČR, v. v. i. 2,6-disubstituované puriny pro použití jako léčiva a farmaceutické přípravky je obsahující

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0633886B1 (fr) * 1992-04-03 2000-10-18 PHARMACIA & UPJOHN COMPANY Amines bicycliques-heterocycliques efficaces pharmaceutiquement
US5929046A (en) * 1994-06-08 1999-07-27 Cancer Research Campaign Technology Limited Pyrimidine and purine derivatives and their use in treating tumour cells
DE19630906A1 (de) * 1996-08-01 1998-02-05 Faber Castell A W Weichminenstift
ATE311884T1 (de) * 1997-07-12 2005-12-15 Cancer Rec Tech Ltd Cyclin-abhängige-kinase inhibierende purinderivate
PA8474101A1 (es) * 1998-06-19 2000-09-29 Pfizer Prod Inc Compuestos de pirrolo [2,3-d] pirimidina
EP1150982B1 (fr) * 1999-02-01 2005-10-12 Cv Therapeutics, Inc. INHIBITEURS PURIQUES DE KINASE DEPENDANTES DES CYCLINES et IkB-alpha
FR2818642B1 (fr) * 2000-12-26 2005-07-15 Hoechst Marion Roussel Inc Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion
US7842693B2 (en) * 2002-06-12 2010-11-30 Chemocentryx, Inc. Substituted piperazines
JP4976852B2 (ja) * 2003-11-10 2012-07-18 ザ スクリプス リサーチ インスティチュート 細胞脱分化を誘導するための組成物および方法

Also Published As

Publication number Publication date
US20080119467A1 (en) 2008-05-22
EP1841769A2 (fr) 2007-10-10
WO2006075094A3 (fr) 2006-12-07
WO2006075094A2 (fr) 2006-07-20
AR052454A1 (es) 2007-03-21
FR2880626A1 (fr) 2006-07-14
JP2008526930A (ja) 2008-07-24

Similar Documents

Publication Publication Date Title
FR2885904B1 (fr) Nouveaux derives du fluorene, compositions les contenant et utilisation
BRPI0819299A2 (pt) Uso de composição, e, composição contendo proteína
FR15C0037I2 (fr) Compositions monodisperses contenant du naloxol pegyle
EP2040708A4 (fr) Compositions contenant de la quercétine
DE602004027964D1 (de) Saugfähiger Artikel
EP1930358A4 (fr) Composition de polyisocyanate et composition de revêtement la contenant
EP2061476A4 (fr) Compositions contenant de la cdp-choline et procédés d'utilisation de celles-ci
EP1562422A4 (fr) Compositions et methodes de prolongement de la survie des plaquettes
EP1506786A4 (fr) Compositions medicinales contenant de la ghreline
BRPI0911688A2 (pt) "compostos de pirimidina, composições e métodos de uso"
FR20C1027I2 (fr) Derives de tiglien-3-one
DK1961744T3 (da) Forbindelse indeholdende basiske grupper samt anvendelse deraf
EP1961753A4 (fr) Derives de la pirazolopyrimidinone, leur preparation et leur utilisation
EP1782803A4 (fr) Composition contenant de la coenzyme q10
FR2903406B1 (fr) Derives de pyrazolylbenzimidazole,compositions les contenant et utilisation
EP1924684A4 (fr) Structure de l'état de transition de 5'-méthylthioadénosine/s-adénosylhomocystéine nucléosidases
FR2884821B1 (fr) Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
FR2880626B1 (fr) Derives de la purine, compositions les contenant et utilisation
CR10229A (es) Derivados de 1,2,4,5,-tetrahidro-3h-benzazepinas, su procedimiento de preparación y las composiciones farmacéuticas que las contienen
MA29030B1 (fr) 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
DE602004018512D1 (de) Stifte zusammensetzungen
DK1670769T3 (da) Benzimidazol-derivater, sammensætninger indeholdende disse, fremstilling deraf og anvendelser deraf
BRPI0615630A2 (pt) composição farmacêutica, e, uso de sertindol
FR2920774B1 (fr) Nouveaux derives de n-phenul acatamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contentant
FR2907453B1 (fr) Nouveaux derives du fluorene,compositions les contenant et utilisation

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20091030